Six genes (GSTA1, GSTA2, NAT8, SLC17A3, SLC17A4, and FABP7) were screened out, downregulating in ccRCC patients with wild-type VHL compared to patients with the mutation (Figure 1A). The gene discussed is NAT8; the disease is nonpapillary renal cell carcinoma.